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Abstract
Background: Synaesthesia is a neurodevelopmental condition in which a sensation in one modality triggers a
perception in a second modality. Autism (shorthand for Autism Spectrum Conditions) is a neurodevelopmental
condition involving social-communication disability alongside resistance to change and unusually narrow interests
or activities. Whilst on the surface they appear distinct, they have been suggested to share common atypical
neural connectivity.
Methods: In the present study, we carried out the first prevalence study of synaesthesia in autism to formally test
whether these conditions are independent. After exclusions, 164 adults with autism and 97 controls completed a
synaesthesia questionnaire, Autism Spectrum Quotient, and Test of Genuineness-Revised (ToG-R) online.
Results: The rate of synaesthesia in adults with autism was 18.9% (31 out of 164), almost three times greater than in
controls (7.22%, 7 out of 97, P <0.05). ToG-R proved unsuitable for synaesthetes with autism.
Conclusions: The significant increase in synaesthesia prevalence in autism suggests that the two conditions may share
some common underlying mechanisms. Future research is needed to develop more feasible validation methods of
synaesthesia in autism.
Background
Synaesthesia occurs in 4% of the population [1]. Autism
spectrum conditions (henceforth, autism) occur in 1% of
the population [2]. If these conditions are independent,
then synaesthesia and autism should co-occur in only 4
in 10,000 people. However, both are thought to involve
atypical neural connectivity [3-5], which may point to a
shared aetiology.
Synaesthesia occurs when the stimulation of one sensory
modality automatically evokes a perception in another
unstimulated modality [6]. The most common forms of
synaesthesia involve written and/or auditory stimuli
triggering colours [1,7]. Individuals with ‘developmental
synaesthesia’ report having the condition for as long as
they can remember [8]. Developmental synaesthesia shows
familial clustering and (as yet unidentified) genetic factors
are likely to play a significant role [9-11]. Developmental
synaesthesia is distinct from ‘acquired synaesthesia’ where
individuals report first experiencing synaesthesia later
in life, after an inducing event such as the use of
hallucinogenic drugs [12]. Developmental synaesthesia
is not easily explained by learning because siblings with
this condition, exposed to similar environments, often
report different colours for the same inducer, or experience
different variants of the trait [10], although this has
been disputed [13]. Crucially, people with developmental
synaesthesia describe their experiences as automatic and
involuntary, in contrast to metaphoric associations that are
voluntary and are not intended to be taken literally [14].
Neuroimaging studies confirm that synaesthesia is
associated with differences in brain structure and/or
function [15-18]. The hyper-connectivity hypothesis
proposes that people with synaesthesia have excessive
neural connections between different regions, connections
that are diminished or absent from unaffected individuals
[5,19-21]. Evidence for this hypothesis comes from a
diffusion tensor imaging study [18] showing that people
with grapheme-colour synaesthesia have increased white
matter connectivity compared to unaffected controls.
Autism (including Asperger syndrome) involves social
and communication difficulties, alongside unusually narrow
interests and activities and resistance to change [22].
Neuroimaging studies of autism indicate that the autistic
brain is anatomically and functionally different from the
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typical brain [3,23,24]. Differences are found in grey and
white matter, and cortical connectivity [25,26]. According
to one hypothesis, autism is associated with a reduction
in long-range neural connections, alongside an increase
in local, short-range connectivity [3,4]. This hypothesis
may explain aspects of autism such as detail-oriented
processing (‘obsessions’). Thus, an increase in local con-
nectivity may play a role in both autism and synaesthesia.
Ten percent of individuals with autism have savant skills
(a skill that is above average for the general population),
and an estimated 50% of savants have autism [27]. Daniel
Tammet, who has both Asperger syndrome and synaesthe-
sia, and who is a memory savant (he memorized Pi to
22,514 decimal places) inspired the hypothesis that
savantism arises in individuals who have both autism and
synaesthesia. This combination of conditions has been
speculated to give rise to strong ‘systemizing’ and ex-
cellent attention to detail, both products of neural
hyper-connectivity [8,28].
Beyond such single-case reports of synaesthesia in
autism, it has been proposed that synaesthesia may be
common in autism [29,30]. The idea has tentative indirect
support from two different lines of investigation. First, a
molecular genetic study of families with auditory-visual
synaesthesia found linkage to an area on chromosome 2,
in a region that had previously been linked to autism
[9]. However, these genetic findings may not overlap
since the study by Asher et al. found considerable gen-
etic heterogeneity across families. Moreover, cAMP-
GEFII, an interesting candidate gene from the linkage
region, harbours rare variants that are associated with aut-
ism but not implicated in synaesthesia. Secondly, an
event-related potential study found that participants
with autism showed occipital (visual cortical) activity
while attending to auditory stimuli [31], although the in-
terpretation of this anomaly is unclear. In the present
study, we carried out the first direct assessment of
overlap between the two conditions.
Methods
In total, 172 adults with autism and 123 typical adults
responded and gave electronic consent. These are the
subset of those who responded from an email sent to
927 adults with autism and 1,364 typical adults. Participants
(aged 18 years old or older) were invited to visit one of
two websites (www.autismresearchcentre.com or www.
cambridgepsychology.com) hosted by the Autism Research
Centre at Cambridge University. Potential participants
received an email inviting them to participate in a study
on synaesthesia in adults with and without autism. The
email defined and briefly described synaesthesia; the
definition of synaesthesiaa was provided in the informed
consent form. In order to reduce sampling bias, the
consent form stressed that all individuals – with autism or
synaesthesia, both, or neither – were eligible to participate.
The study was approved by the Psychology Research
Ethics Committee of the University of Cambridge. All
participants with autism had a diagnosis from a clinical
psychologist or psychiatrist from a recognized clinic. All
participants were asked to complete two questionnaires
online:
(a) The Synaesthesia Questionnaire, adapted from
previous studies [9,32]. This was used as a further
form of self-report of synaesthesia and to document
the subtype(s) experienced. In order to screen out
acquired synaesthesia, it also asked a series of
questions used as exclusion criteria: whether the
person had any medical conditions affecting vision
(e.g., colour blindness), any medical condition
affecting the brain (e.g., head injury, epilepsy, brain
tumour, or stroke), any history of hallucinogenic
Figure 1 Scoring protocol for the ToG-R. Each box represents a
swatch on the colour chart. From Asher et al. (2006) [32].
Table 1 Participant characteristics
Number who replied Number excluded Final number Age in years (SD) % Attended university % Female % Right-handed
Autism 172 8 164 39.52 (13.15) 60.4% 45.7% 77.6%*
Typical 123 26 97 41.21 (13.37) 68.0% 74.2%* 83.9%*
*P <0.05.
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drug use, and how long the person had experienced
synaesthesia. Conservative inclusion criteria were
used to judge if any individual had synaesthesia. If
any of these questions were answered positively, or
if synaesthesia was first experienced in adulthood,
then the person was conservatively judged not to
have synaesthesia.
(b) The Autism Spectrum Quotient (AQ) [33]. This
was used to measure the number of autistic traits, as
a check on an autism diagnosis. We excluded from
the control group anyone scoring >25, to ensure the
controls were representative. This resulted in 26
individuals being excluded.
(c) The Test of Genuineness-Revised (ToG-R) [32].
This was used to validate any self-reported
auditory-visual forms of grapheme-colour (GC) and
sound-colour (SC) synaesthesia and was sent to all
participants in order to detect true and false
positives and negatives. The ToG-R is a colour chart
that measures consistency in a participant’s reported
colour associations to either letters (GC) or sounds
(SC) over time. Participants are asked to choose
from a colour chart to indicate the closest match
evoked by a word (GC) or a sound (SC), and are
then re-tested after an interval of at least a month,
without warning. Previous work has found that
synaesthetes far out-perform controls in the
consistency across time in their colour reports to
specific stimuli. Consistency scores were based on a
point system created by Asher et al. [32] (Figure 1).




Points awarded for itemsð Þ
Total number of items  3
 
 100
The total number of points for every item in the test
was added (e.g., for the SC ToG-R, the total number of
points awarded for stimuli 1–99, inclusive) and this
number was divided by the total number of items with
valid colour responses multiplied by three, the maximum
number of points per item. This is the total number of
possible points on the test (e.g., if a person gave valid
answers for all 99 sounds, the total number of points
possible would be 297). The total number of actual
points was divided by the total number of possible points.
To yield a percentage, this number was multiplied by 100.
Results
As stated above, 172 adults with autism and 123 typical
adults responded and gave electronic consent. Table 1
shows the participant characteristics.
Eight of the adults with autism were excluded for
reporting a self- but not clinician-diagnosed autism. As
expected, significant differences were found for mean AQ
scores between those with autism (x = 39.63, SD = 6.42)
and controls (x = 16.41, SD = 5.37) [t [213] = 26.83,
P <0.001]. Twenty-six of the typical adults were excluded
for scoring >25 on the AQ, leaving a final non-autistic
group of n = 97. No group differences were found in age
or education, the latter measured by the rate of university
attendance (both P >0.05). There was a difference in
handedness and in sex ratio, in line with previous
studies of autism (both P <0.05) [34,35]. In the autism
group, n = 9 (5.5%) had high functioning autism, n = 153
(93%) had Asperger syndrome, and n = 2 (1.2%) had
pervasive developmental disorder, not otherwise specified.
Table 2 The number who replied and the number who showed Grapheme-Colour (GC), Sound-Colour (SC), or other
variants of synaesthesia, or no synaesthesia
n Number with
GC but no SC
synaesthesia
Number with













Autism 164 5 8 13 5 31 (18.9%)* 133*
Typical 97 2 2 1 2 7 (7.22%) 90
(*P <0.05). Statistical analyses were completed only for number and percent of participants reporting synesthesia.
Figure 2 The percentage of people with synaesthesia in each
group (autism vs. typical controls).
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Among the 164 people with autism, 31 (14 male) met
inclusion criteria for synaesthesiab (a rate of synaesthesia
of 18.9%), which was significantly higher than the 7.22%
(n = 7 (1 male)) rate of synaesthesia among the 97 controls
(χ2 (1, n = 261) = 6.69, p <0.05); 95% confidence intervals
for the rate of synaesthesia in autism are ±5.99, the
range for the true autism population proportion being
12.91% to 24.89%; 95% confidence intervals for the rate
of synaesthesia in controls are ±5.15, the range for the true
control population proportion being 2.07% to 12.37%
(Figure 2). As Figure 2 shows, there is no overlap in the
rates of synaesthesia in autism vs. controls. Tables 2
and 3 show an overview of what types of synaesthesia
were reported in each group, and Table 4 shows the
number of participants with any type of synaesthesia
who completed a GC ToG-R and/or a SC ToG-R.
Because the response rates were low in all cells in
Table 4, no statistical analysis was conducted. Telephone
follow-up to find out why ToG-Rs were not being
completed revealed that participants with autism reported
fatigue from the 241 possible choices. We explored if
fewer colours would be less stressful [36] but participants
with autism reported it would be more stressful to be
unable to choose the right colour than to have to choose
from a large collection of colours.
Discussion
Our findings indicate that synaesthesia is significantly
more common in adults with autism than in typical
adults, based on self-report. The rate of synaesthesia in
autism (18.9%) was almost three times greater than in
the typical sample (7.22%), whose rate overlaps with
the 4% reported previously (given confidence intervals)
[1]. We predicted that synaesthesia would be more
prevalent in autism than in controls if these conditions
were interdependent, perhaps because they share some
underlying biological causal factor, such as local neural
hyper-connectivity. Four mechanisms have been proposed
to account for neural hyper-connectivity: faulty axonal
pruning, differences in axon guidance, disinhibition, and
atypical border formation [37]. Interestingly, a recent study
has revealed a significant phenotypic and genetic overlap
between synaesthesia and absolute pitch [38], a trait that
has also been reported to occur at increased frequency in
people with autism [39,40]. This strengthens the case that
autism and synaesthesia are linked at multiple levels.
It is possible that the elevated rate of synaesthesia in
autism might be explained by people with autism being
more likely to report abnormal sensory perceptual
experiences than people without the condition. Although
it is true that adults with autism score highly on sensory
sensitivity questionnaires [41], we doubt this can explain
the current results, because our sample included some
individuals with autism (n = 3) who claimed they did not
have synaesthesia, but were judged by the experimenters
to have synaesthesia on the basis of their questionnaire
responses. Because they reported not having synaesthesia,
we conservatively considered them to be non-synaes-
thetes. These participants with autism declared that
they did not have synaesthesia because they said they
were uncertain whether their experiences counted. Thus,
the high rate of synaesthesia in autism is unlikely to be an
over-estimate, and could even be an under-estimate. A
related possible explanation of the comorbid association
might be failure in inhibition/greater cortical excitation
[42]. This is in line with the high scores on sensory
sensitivity questionnaires [43], and is compatible with
the finding that synaesthesia occurs more frequently
in autism than in the general population.
Table 4 The number in each group who completed a GC ToG-R or SC ToG-R
Number who completed a
GC ToG-R, of those reporting
GC (but not SC) synaesthesia
Number who completed a SC
ToG-R, of those reporting SC
(but not GC) synaesthesia
Number who completed SC and
GC ToG-R, of those reporting SC
and GC synaesthesia
Autism 0 /5 2 /8 1 /13
Typical 1 /2 1 /2 1 /1
Table 3 Number of synaesthetes with and without autism























(Note: Cases can be in more than one cell due to co-occurrence).
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There are several limitations of this study. First, we were
unable to collect complete consistency tests to validate the
prevalence estimates, which will be important to explore
in future work. It may be the case that traditional ToGs
are not suitable for people with autism and that these
will require modification. If the ToG-R is used in future
studies, it should be completed in person, so that the
experimenter can ensure that there is no missing data.
Future studies could also consider using computerized
immediate retests [44] as alternative ways for validation. It
will also be interesting to test if the current results extend
to children with autism, or to more impaired individuals
with autism, since our sample only included high-function-
ing adults. Second, response rates to the initial invitations
were low, which is not unusual in survey research [45],
therefore, other studies must become available to confirm
the observed synaesthesia prevalence rates observed, and
extrapolation from the current study should be done with
caution until other such surveys have been conducted.
Third, this question has not yet been tested in different
clinical groups to assess if this link is specific to autism.
Fourth, it would be interesting to test how people with
autism and synaesthesia differ from those with autism
alone. As far as we know, there has not yet been a study
investigating autism vs. synaesthesia vs. comorbidity
between these two conditions using MRI or fMRI,
which should now become a research priority in this area.
Fifth, we recognize that the Synaesthesia Questionnaire is
a self-report instrument that in future studies needs to be
evaluated in terms of its reliability and validity. Most
importantly, the next step in future research must be to
explore the biological mechanisms causing the elevated
rate of synaesthesia in autism.
Conclusions
The significant increase in synaesthesia prevalence in
autism suggests that the two conditions may share some
common underlying mechanisms. Future research needs to
develop more feasible validation methods of synaesthesia
in autism.
Endnotes
aSynaesthesia is a condition in which a sensation in
one sensory modality automatically triggers a response
in a different sensory modality. For instance, a person
with ‘coloured hearing’ synaesthesia sees colours after
hearing sounds… Although most synaesthetic responses
are visual, synaesthesia can involve any pair of senses.
Some people even experience more than one type of
synaesthesia. The following are examples of what people
with synaesthesia might say, “The letter q is dark brown”;
“The sound of a bell is red”; “The word hello tastes like
coffee”; “A toothache is shaped like a rectangle”.
bTo be considered synaesthetic, participants had to
report that they experienced synaesthesia and could not
meet any of the exclusion criteria (see Methods).
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